{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:28:38Z","timestamp":1750681718950},"reference-count":26,"publisher":"Japanese Society of Toxicology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2022]]},"DOI":"10.2131\/jts.47.457","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T22:16:51Z","timestamp":1667254611000},"page":"457-466","source":"Crossref","is-referenced-by-count":2,"title":["Toxicological effects of two metabolites derived from &lt;i&gt;o&lt;\/i&gt;-toluidine and &lt;i&gt;o&lt;\/i&gt;-anisidine after 28-day oral administration to rats"],"prefix":"10.2131","volume":"47","author":[{"given":"Takeshi","family":"Toyoda","sequence":"first","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Akane","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"B\u00f6hm, F., Schmid, D., Denzinger, S., Wieland, W.F. and Richter, E. (2011): DNA adducts of <i>ortho<\/i>-toluidine in human bladder. Biomarkers, <b>16<\/b>, 120-128.","DOI":"10.3109\/1354750X.2010.534556"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018): Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., <b>68<\/b>, 394-424.","DOI":"10.3322\/caac.21492"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cohen, S.M. (1998): Urinary bladder carcinogenesis. Toxicol. Pathol., <b>26<\/b>, 121-127.","DOI":"10.1177\/019262339802600114"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cohen, S.M. and Arnold, L.L. (2016): Critical role of toxicologic pathology in a short-term screen for carcinogenicity. J. Toxicol. Pathol., <b>29<\/b>, 215-227.","DOI":"10.1293\/tox.2016-0036"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cumberbatch, M.G., Cox, A., Teare, D. and Catto, J.W. (2015): Contemporary occupational carcinogen exposure and bladder cancer: A systematic review and meta-analysis. JAMA Oncol., <b>1<\/b>, 1282-1290.","DOI":"10.1001\/jamaoncol.2015.3209"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Guo, J., Villalta, P.W., Weight, C.J., Bonala, R., Johnson, F., Rosenquist, T.A. and Turesky, R.J. (2018): Targeted and untargeted detection of DNA adducts of aromatic amine carcinogens in human bladder by ultra-performance liquid chromatography-high-resolution mass spectrometry. Chem. Res. Toxicol., <b>31<\/b>, 1382-1397.","DOI":"10.1021\/acs.chemrestox.8b00268"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Hecht, S.S., El-Bayoumy, K., Rivenson, A. and Fiala, E. (1982): Comparative carcinogenicity of <i>o<\/i>-toluidine hydrochloride and <i>o<\/i>-nitrosotoluene in F-344 rats. Cancer Lett., <b>16<\/b>, 103-108.","DOI":"10.1016\/0304-3835(82)90097-0"},{"key":"8","unstructured":"International Agency for Research on Cancer. (2010): <i>ortho<\/i>-. Toluidine. IARC Monogr. Eval. Carcinog. Risk Chem. Hum., <b>99<\/b>, 407-469."},{"key":"9","unstructured":"International Agency for Research on Cancer. (2021): <i>ortho<\/i>-Anisidine and <i>ortho<\/i>-anisidine hydrochloride. IARC Monogr Identification Carcinog Hazards Hum, <b>127<\/b>, 45-79."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kobayashi, T., Kishimoto, S., Watanabe, S., Yoshioka, Y., Toyoda, T., Ogawa, K., Watanabe, K., Totsuka, Y., Wakabayashi, K. and Miyoshi, N. (2022): Cytotoxic homo- and hetero-dimers of <i>o<\/i>-toluidine, <i>o<\/i>-anisidine, and aniline formed by <i>in vitro<\/i> metabolism. Chem. Res. Toxicol., <b>35<\/b>, 1625-1630.","DOI":"10.1021\/acs.chemrestox.2c00226"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kobayashi, T., Toyoda, T., Tajima, Y., Kishimoto, S., Tsunematsu, Y., Sato, M., Matsushita, K., Yamada, T., Shimamura, Y., Masuda, S., Ochiai, M., Ogawa, K., Watanabe, K., Takamura-Enya, T., Totsuka, Y., Wakabayashi, K. and Miyoshi, N. (2021): <i>o<\/i>-Anisidine dimer, 2-methoxy-<i>N<\/i><sup>4<\/sup>-(2-methoxyphenyl) benzene-1,4-diamine, in rat urine associated with urinary bladder carcinogenesis. Chem. Res. Toxicol., <b>34<\/b>, 912-919.","DOI":"10.1021\/acs.chemrestox.0c00536"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Motoyama, S., Takeiri, A., Tanaka, K., Harada, A., Matsuzaki, K., Taketo, J., Matsuo, S., Fujii, E. and Mishima, M. (2018): Advantages of evaluating \u03b3H2AX induction in non-clinical drug development. Genes Environ., <b>40<\/b>, 10.","DOI":"10.1186\/s41021-018-0098-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Naiman, K., Drac\u00ednsk\u00fd, M., Hodek, P., Mart\u00ednkov\u00e1, M., Schmeiser, H.H., Frei, E. and Stiborov\u00e1, M. (2012): Formation, persistence, and identification of DNA adducts formed by the carcinogenic environmental pollutant <i>o<\/i>-anisidine in rats. Toxicol. Sci., <b>127<\/b>, 348-359.","DOI":"10.1093\/toxsci\/kfs104"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Nakano, M., Omae, K., Takebayashi, T., Tanaka, S. and Koda, S. (2018): An epidemic of bladder cancer: ten cases of bladder cancer in male Japanese workers exposed to <i>ortho<\/i>-toluidine. J. Occup. Health, <b>60<\/b>, 307-311.","DOI":"10.1539\/joh.2017-0220-OA"},{"key":"15","unstructured":"National Toxicology Program. (1978): Bioassay of <i>o<\/i>-anisidine hydrochloride for possible carcinogenicity. Natl. Cancer Inst. Carcinog. Tech. Rep. Ser., <b>89<\/b>, 1-149."},{"key":"16","unstructured":"National Toxicology Program. (1979): Bioassay of <i>o<\/i>-toluidine hydrochloride for possible carcinogenicity. Natl. Cancer Inst. Carcinog. Tech. Rep. Ser., <b>153<\/b>, 1-147."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Redon, C.E., Weyemi, U., Parekh, P.R., Huang, D., Burrell, A.S. and Bonner, W.M. (2012): \u03b3-H2AX and other histone post-translational modifications in the clinic. Biochim. Biophys. Acta, <b>1819<\/b>, 743-756.","DOI":"10.1016\/j.bbagrm.2012.02.021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S. and Bonner, W.M. (1998): DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., <b>273<\/b>, 5858-5868.","DOI":"10.1074\/jbc.273.10.5858"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Tajima, Y., Toyoda, T., Hirayama, Y., Matsushita, K., Yamada, T., Ogawa, K., Watanabe, K., Takamura-Enya, T., Totsuka, Y., Wakabayashi, K. and Miyoshi, N. (2020): Novel <i>o<\/i>-toluidine metabolite in rat urine associated with urinary bladder carcinogenesis. Chem. Res. Toxicol., <b>33<\/b>, 1907-1914.","DOI":"10.1021\/acs.chemrestox.0c00098"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Toyoda, T., Cho, Y.M., Akagi, J., Mizuta, Y., Hirata, T., Nishikawa, A. and Ogawa, K. (2015): Early detection of genotoxic urinary bladder carcinogens by immunohistochemistry for \u03b3-H2AX. Toxicol. Sci., <b>148<\/b>, 400-408.","DOI":"10.1093\/toxsci\/kfv192"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Toyoda, T., Matsushita, K., Morikawa, T., Yamada, T., Miyoshi, N. and Ogawa, K. (2019): Distinct differences in the mechanisms of mucosal damage and \u03b3-H2AX formation in the rat urinary bladder treated with <i>o<\/i>-toluidine and <i>o<\/i>-anisidine. Arch. Toxicol., <b>93<\/b>, 753-762.","DOI":"10.1007\/s00204-019-02396-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Toyoda, T. and Ogawa, K. (2022): Early detection of urinary bladder carcinogens in rats by immunohistochemistry for \u03b3-H2AX: a review from analyses of 100 chemicals. J. Toxicol. Pathol., in press.","DOI":"10.1293\/tox.2022-0061"},{"key":"23","unstructured":"Weisburger, E.K., Russfield, A.B., Homburger, F., Weisburger, J.H., Boger, E., Van Dongen, C.G. and Chu, K.C. (1978): Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity. J. Environ. Pathol. Toxicol., <b>2<\/b>, 325-356."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Yamada, T., Toyoda, T., Matsushita, K., Akane, H., Morikawa, T., Cho, Y.M. and Ogawa, K. (2022): Persistent \u03b3-H2AX formation and expression of stem cell markers in <i>N<\/i>-butyl-<i>N<\/i>-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats. Toxicol. Sci., <b>189<\/b>, 51-61.","DOI":"10.1093\/toxsci\/kfac064"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yamada, T., Toyoda, T., Matsushita, K., Cho, Y.M., Akagi, J., Morikawa, T., Mizuta, Y. and Ogawa, K. (2021): Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for \u03b3-H2AX. Arch. Toxicol., <b>95<\/b>, 715-726.","DOI":"10.1007\/s00204-020-02950-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Yamada, T., Toyoda, T., Matsushita, K., Morikawa, T. and Ogawa, K. (2020): Dose dependency of \u03b3-H2AX formation in the rat urinary bladder treated with genotoxic and nongenotoxic bladder carcinogens. J. Appl. Toxicol., <b>40<\/b>, 1219-1227.","DOI":"10.1002\/jat.3978"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/11\/47_457\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T04:29:42Z","timestamp":1667622582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/11\/47_457\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.47.457","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}